DDS-3D: Development of a hybrid SLA inkjet process for the production of jaw implants with local drug depots
The aim of the project is to develop an additively manufactured jaw implant with a time-controllable drug release to support the healing process and osteogenesis of the jawbone. The implant will be manufactured using a hybrid 3D printing process. To support the healing of the implant and the bone formation, a corresponding active ingredient is introduced into the polymer implant. This is incorporated into special depots in the implant during the printing process and then released in the tissue by diffusion over a controlled period of time. In cooperation with the project partners, the model of a jaw implant will be created and printed with innovative photopolymers, as well as provided with drug depots in a specified size and position. For this purpose, a combined microstereolithography system will be set up.
The polymer implant is intended to reduce the side effects of conventional jaw implants made of titanium. To achieve this, mechanical properties are sought that are as similar as possible to the natural jawbone. The osteosynthesis is to be promoted by appropriate surface design and the release of the incorporated drug.
Contact: Ahmed Sannan M.Sc
Funding: Bundesministerium für Wirtschaft und Energie (BMWi)
Duration: 09/2021 – 02/2024
- M.C. Medizintechnik-Export GmbH & Co. KG,
- MEGADENTA Dentalprodukte GmbH,
- Institut für Biomedizinische Technik der Universitätsmedizin Rostock